Glucose transporter type I (GLUT1), also known as SCL2A1, is a glucose transporter present in the blood-brain barrier as well as erythrocytes. GLUT1 overexpression is associated with tumor progression or poor prognoses of bladder, breast, cervical, colon, and lung carcinomas, as well as mesothelioma. Anti-GLUT1 is useful for distinguishing malignant mesothelioma (GLUT1(+)) from reactive mesothelium (GLUT1(-)).
|Positive Control||Colorectal Carcinoma, Malignant Mesothelioma|
|Dilution Range||1:100 - 1:200|